191 related articles for article (PubMed ID: 19490048)
1. Seizure frequency in pregnant women treated with lamotrigine monotherapy.
Sabers A; Petrenaite V
Epilepsia; 2009 Sep; 50(9):2163-6. PubMed ID: 19490048
[TBL] [Abstract][Full Text] [Related]
2. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.
de Haan GJ; Edelbroek P; Segers J; Engelsman M; Lindhout D; Dévilé-Notschaele M; Augustijn P
Neurology; 2004 Aug; 63(3):571-3. PubMed ID: 15304599
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
[TBL] [Abstract][Full Text] [Related]
4. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register.
Vajda FJ; Graham JE; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
Seizure; 2010 Nov; 19(9):558-61. PubMed ID: 20739196
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
Ohman I; Beck O; Vitols S; Tomson T
Epilepsia; 2008 Jun; 49(6):1075-80. PubMed ID: 18076642
[TBL] [Abstract][Full Text] [Related]
6. 2005 AES annual course: evidence used to treat women with epilepsy.
Pennell PB
Epilepsia; 2006; 47 Suppl 1():46-53. PubMed ID: 17044826
[TBL] [Abstract][Full Text] [Related]
7. Algorithm for lamotrigine dose adjustment before, during, and after pregnancy.
Sabers A
Acta Neurol Scand; 2012 Jul; 126(1):e1-4. PubMed ID: 22150770
[TBL] [Abstract][Full Text] [Related]
8. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
9. Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
Tompson DJ; Ali I; Oliver-Willwong R; Job S; Zhu L; Lemme F; Hammer AE; Vuong A; Messenheimer JA
Epilepsia; 2008 Mar; 49(3):410-7. PubMed ID: 17825077
[TBL] [Abstract][Full Text] [Related]
10. Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
EURAP Study Group
Neurology; 2006 Feb; 66(3):354-60. PubMed ID: 16382034
[TBL] [Abstract][Full Text] [Related]
11. The impact of pregnancy and childbirth on the metabolism of lamotrigine.
Pennell PB; Newport DJ; Stowe ZN; Helmers SL; Montgomery JQ; Henry TR
Neurology; 2004 Jan; 62(2):292-5. PubMed ID: 14745072
[TBL] [Abstract][Full Text] [Related]
12. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.
Tomson T; Luef G; Sabers A; Pittschieler S; Ohman I
Neurology; 2006 Oct; 67(7):1297-9. PubMed ID: 17030773
[TBL] [Abstract][Full Text] [Related]
13. Effects of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis.
Pirie DA; Al Wattar BH; Pirie AM; Houston V; Siddiqua A; Doug M; Bagary M; Greenhill L; Khan KS; McCorry D; Thangaratinam S
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():26-31. PubMed ID: 24211103
[TBL] [Abstract][Full Text] [Related]
14. Individual changes in lamotrigine plasma concentrations during pregnancy.
Petrenaite V; Sabers A; Hansen-Schwartz J
Epilepsy Res; 2005 Jul; 65(3):185-8. PubMed ID: 16084694
[TBL] [Abstract][Full Text] [Related]
15. Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administration.
Nielsen KA; Dahl M; Tømmerup E; Hansen Bá; Erdal J; Wolf P
Epilepsy Behav; 2008 Oct; 13(3):470-3. PubMed ID: 18611447
[TBL] [Abstract][Full Text] [Related]
16. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.
Pennell PB; Peng L; Newport DJ; Ritchie JC; Koganti A; Holley DK; Newman M; Stowe ZN
Neurology; 2008 May; 70(22 Pt 2):2130-6. PubMed ID: 18046009
[TBL] [Abstract][Full Text] [Related]
17. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
Kim HJ; Kim TE; Joo EY; Seo DW; Lee SY; Hong SB
Clin Chim Acta; 2015 Jan; 438():269-73. PubMed ID: 25218785
[TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine in pregnancy: clinical experience in Argentina.
Meischenguiser R; D'Giano CH; Ferraro SM
Epilepsy Behav; 2004 Apr; 5(2):163-7. PubMed ID: 15123016
[TBL] [Abstract][Full Text] [Related]
19. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
[TBL] [Abstract][Full Text] [Related]
20. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
